
Pediatric Hematologist-Oncologist

No OPD information available
Hemolytic Disease of the Newborn
Newborn Polycythemia
Twin-To-Twin Transfusion Syndrome
Alpha Thalassemia
Anemia
Autoimmune Hemolytic Anemia
Congenital Diaphragmatic Hernia
Diaphragmatic Hernia
Endoscopy
Fetal Edema
Hernia
High Blood Pressure in Infants
Hydrops Fetalis
Infant Respiratory Distress Syndrome
Intrauterine Growth Restriction
Intraventricular Hemorrhage of the Newborn
Myelomeningocele
Necrotizing Enterocolitis
Parainfluenza
Patent Ductus Arteriosus
Placenta Previa
Pleural Effusion
Polyhydramnios
Tracheal Agenesis
VACTERL Association
Glenn J. Gardener is a male healthcare provider who helps babies and children with various medical conditions. He specializes in treating problems like newborn diseases, hernias, high blood pressure in babies, and breathing difficulties. Gardener also deals with issues related to blood disorders, lung problems, and birth defects.
He uses special skills and treatments to care for his patients, such as endoscopy and managing conditions like anemia and autoimmune diseases. Gardener communicates with patients in a kind and understanding way, which helps them feel comfortable and trust him.
To stay updated with the latest medical knowledge, Gardener reads research articles and attends conferences. He works closely with other medical professionals to provide the best care for his patients. Gardener's relationships with his colleagues are positive, and they collaborate well to improve patient outcomes.
Gardener's work has had a positive impact on many patients' lives by helping them overcome serious health challenges. He has contributed to medical knowledge through publications like "Feasibility for non-invasive prenatal fetal blood group and platelet genotyping" in a respected medical journal.
Although one of his clinical trials was terminated, Gardener continues to explore new treatments and approaches to improve healthcare for pregnant women and infants. Overall, Glenn J. Gardener is a dedicated healthcare provider who strives to make a difference in the lives of his patients.
Enrollment Status: Terminated
Published: February 20, 2025
Intervention Type: Biological, Drug
Study Drug: RSV Maternal vaccine
Study Phase: Phase 3
